Conserved synthetic peptides from the hemagglutinin of influenza viruses induce broad humoral and T-cell responses in a pig model

PLoS ONE

Volumn 7, Issue 7, 2012, Pages

  Vergara Alert, Júlia ^a   Argilaguet, Jordi M ^a,d   Busquets, Núria ^a   Ballester, Maria ^a   Martín Valls, Gerard E ^a   Rivas, Raquel ^a   López Soria, Sergio ^a   Solanes, David ^a   Majó, Natàlia ^a   Segalés, Joaquim ^a   Veljkovic, Veljko ^b   Rodríguez, Fernando ^a   Darji, Ayub ^a,c  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b UNIVERSITY OF BELGRADE   (Serbia)

^c IRTA   (Spain)

^d UNIVERSITAT POMPEU FABRA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; HEMAGGLUTININ; HEMAGGLUTININ SUBUNIT 1; INFLUENZA VACCINE; PEPTIDE VACCINE; UNCLASSIFIED DRUG; VIN1 VACCINE;

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; DNA FLANKING REGION; DRUG EFFICACY; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOGENICITY; INFLUENZA A (H1N1); NONHUMAN; NUCLEOTIDE SEQUENCE; PANDEMIC INFLUENZA; PROTEIN LOCALIZATION; SWINE; T LYMPHOCYTE; TREATMENT RESPONSE; VIRAL CLEARANCE; VIRUS ISOLATION; VIRUS REPLICATION;

ANIMALS; ANTIBODIES, VIRAL; ANTIBODY SPECIFICITY; BRONCHOALVEOLAR LAVAGE; CONSERVED SEQUENCE; DOGS; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; HUMANS; IMMUNITY, CELLULAR; IMMUNITY, HUMORAL; IMMUNIZATION; INFLUENZA A VIRUS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA A VIRUS, H5N1 SUBTYPE; MADIN DARBY CANINE KIDNEY CELLS; PANDEMICS; PEPTIDE FRAGMENTS; SPECIES SPECIFICITY; SWINE; T-LYMPHOCYTES; VACCINES, SYNTHETIC; VIRAL VACCINES; VIRUS REPLICATION;

ANIMALIA; AVES; ORTHOMYXOVIRIDAE; SUIDAE;

EID: 84864008973     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0040524     Document Type: Article

References (26)

1. Ito T, Couceiro JN, Kelm S, Baum LG, Krauss S, et al. (1998) Molecular basis for the generation in pigs of influenza A viruses with pandemic potential. J Virol 72: 7367-7373.
2. Vincent AL, Ma W, Lager KM, Janke BH, Richt JA, (2008) Swine influenza viruses a North American perspective. Adv Virus Res 72: 127-154.
3. Neumann G, Noda T, Kawaoka Y, (2009) Emergence and pandemic potential of swine-origin H1N1 influenza virus. Nature 459: 931-939.
4. Wilson IA, Skehel JJ, Wiley DC, (1981) Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 A resolution. Nature 289: 366-373.
5. Steel J, Lowen AC, Wang TT, Yondola M, Gao Q, et al. (2010) Influenza virus vaccine based on the conserved hemagglutinin stalk domain. MBio 1.
6. Veljkovic V, Niman HL, Glisic S, Veljkovic N, Perovic V, et al. (2009) Identification of hemagglutinin structural domain and polymorphisms which may modulate swine H1N1 interactions with human receptor. BMC Struct Biol 9: 62.
7. Veljkovic V, Veljkovic N, Muller CP, Muller S, Glisic S, et al. (2009) Characterization of conserved properties of hemagglutinin of H5N1 and human influenza viruses: possible consequences for therapy and infection control. BMC Struct Biol 9: 21.
8. Matrosovich M, Tuzikov A, Bovin N, Gambaryan A, Klimov A, et al. (2000) Early alterations of the receptor-binding properties of H1, H2, and H3 avian i nfluenza virus hemagglutinins after their introduction into mammals. J Virol 74: 8502-8512.
9. Barnard DL, (2009) Animal models for the study of influenza pathogenesis and therapy. Antiviral Res 82: A110-122.
10. Rothkotter HJ, Sowa E, Pabst R, (2002) The pig as a model of developmental immunology. Hum Exp Toxicol 21: 533-536.
11. Busquets N, Segales J, Cordoba L, Mussa T, Crisci E, et al. (2010) Experimental infection with H1N1 European swine influenza virus protects pigs from an infection with the 2009 pandemic H1N1 human influenza virus. Vet Res 41: 74.
12. El Bakkouri K, Descamps F, De Filette M, Smet A, Festjens E, et al. (2011) Universal vaccine based on ectodomain of matrix protein 2 of influenza A: Fc receptors and alveolar macrophages mediate protection. J Immunol 186: 1022-1031.
13. Kitikoon P, Vincent AL, Janke BH, Erickson B, Strait EL, et al. (2009) Swine influenza matrix 2 (M2) protein contributes to protection against infection with different H1 swine influenza virus (SIV) isolates. Vaccine 28: 523-531.
14. Tompkins SM, Zhao ZS, Lo CY, Misplon JA, Liu T, et al. (2007) Matrix Protein 2 Vaccination and Protection against Influenza Viruses, Including Subtype H5N1. Emerg Infec Dis 13: 426-435.
15. Wang TT, Tan GS, Hai R, Pica N, Ngai L, et al. (2010) Vaccination with a synthetic peptide from the influenza virus hemagglutinin provides protection against distinct viral subtypes. Proc Natl Acad Sci U S A 107: 18979-18984.
16. Molder T, Adojaan M, Kaldma K, Ustav M, Sikut R, (2009) Elicitation of broad CTL response against HIV-1 by the DNA vaccine encoding artificial multi-component fusion protein MultiHIV-study in domestic pigs. Vaccine 28: 293-298.
17. Christensen JP, Doherty PC, Branum KC, Riberdy JM, (2000) Profound protection against respiratory challenge with a lethal H7N7 influenza A virus by increasing the magnitude of CD8(+) T-cell memory. J Virol 74: 11690-11696.
18. Riberdy JM, Flynn KJ, Stech J, Webster RG, Altman JD, et al. (1999) Protection against a lethal avian influenza A virus in a mammalian system. J Virol 73: 1453-1459.
19. Hillaire ML, van Trierum SE, Kreijtz JH, Bodewes R, Geelhoed-Mieras MM, et al. (2011) Cross-protective immunity to influenza pH1N1 2009 viruses induced by seasonal A(H3N2) virus is mediated by virus-specific T cells. J Gen Virol.
20. Stanekova Z, Vareckova E, (2010) Conserved epitopes of influenza A virus inducing protective immunity and their prospects for universal vaccine development. Virol J 7: 351.
21. Watanabe Y, Ibrahim MS, Ellakany HF, Kawashita N, Mizuike R, et al. (2011) Acquisition of human-type receptor binding specificity by new H5N1 influenza virus sublineages during their emergence in birds in Egypt. PLoS Pathog 7: e1002068.
22. Reed LJ, Muench H, (1938) A simple method of estimating fifty per cent endpoint. A J Hygiene 27: 493-497.
23. World Organisation for Animal Health, OIE (2008) Manual for Diagnostic Tests and Vaccines for Terrestrial Animals. OIE 1130-1131.
24. Sirskyj D, Weltzin R, Golshani A, Anderson D, Bozic J, et al. (2010) Detection of influenza A and B neutralizing antibodies in vaccinated ferrets and macaques using specific biotin-streptavidin conjugated antibodies. J Virol Methods 163: 459-464.
25. Argilaguet JM, Perez-Martin E, Gallardo C, Salguero FJ, Borrego B, et al. (2011) Enhancing DNA immunization by targeting ASFV antigens to SLA-II bearing cells. Vaccine 29: 5379-5385.
26. Ballester M, Rodriguez-Carino C, Perez M, Gallardo C, Rodriguez JM, et al. (2011) Disruption of Nuclear Organization during the Initial Phase of African Swine Fever Virus Infection. J Virol 85: 8263-8269.